The U.S. government is particularly concerned about high healthcare expenditures associated with the treatment of behavioral health-related disorders or mental diseases. According to the 2020 National Survey on Drug Use and Health (NSDUH), depression is a prevalent mental condition in the United States, affecting about 21.0 million persons. The prevalence of mental health problems is increasing significantly among children and adults in the United States. According to the National Alliance on Mental Illness, around 51.5 million adults and 7.7 million children were suffering from mental illness in 2019.
Over the past few years, the prevalence of mental disorders in the U.S. has been increasing. Work stress, unhealthy lifestyles, COVID-19, loss of loved ones, substance addiction, and others are major factors contributing to the prevalence of mental disorders in the country. According to John Hopkins Medicine, every 1 in 4 adults have a diagnosable psychiatric disorder. In addition, 18% of the U.S. population have anxiety disorders. As per The Anxiety and Depression Association of America, around 19 million adults have specific phobias. OCD (obsessive-compulsive disorder) is affecting 2.2 million people in the U.S. This is resulting in high demand for behavioral health services and visits to psychiatric hospitals and rehabilitation centers.
According to the Substance Abuse and Mental Health Services Administration (SAMHSA) National Survey on Drug Use and Health, the impact of substance abuse is estimated to be worth USD 600 billion every year in the U.S. The administration stated that substance abuse leads to a loss of productivity and increases the healthcare cost burden. Behavioral health care providers help reduce the costs related to substance abuse by providing value-based medicine programs and preventing hospital readmissions.
Furthermore, in October 2021, the Centers for Disease Control and Prevention (CDC) began four complementary education efforts focused on young adults aged 18–34 to prevent deaths due to drug overdose. The campaigns educate people on the prevalence and hazards of fentanyl, the risks and repercussions of drug mixing, the life-saving efficacy of naloxone, and the necessity of decreasing the stigma associated with drug use to encourage treatment and recovery. Such efforts and initiatives enhance the knowledge about substance addiction treatment among the dependent population, which boosts market growth.
While the majority of the medical and healthcare community has made the switch to electronic health records over the last decade, behavioral health providers have lagged, creating challenges in integrating treatment for behavioral health patients. EHRs are used at a rate of 46% in psychiatric facilities, compared to 96% in general medicine and surgical practices. According to the MACPAC report, the same percentage of office-based physicians practicing psychiatry is 61%, compared to over 93% in everything from general practice and surgery to urology and cardiology.
A panel of experts outlined the causes for behavioral health's lack of EHRs during a September 2021 public meeting of the Medicaid and CHIP Payment and Access Commission (MACPAC). According to a review of these MACPAC findings, behavioral health providers' reluctance to use EHRs is due to four factors, the most significant of which is that these practices, which include psychologists, social workers, and marriage and family therapists, were not eligible for the 2009 incentive program. Without financial incentives and experience with the previous system, many behavioral health professionals continued to maintain their previous methods of health and medical record keeping. Behavioral health professionals are typically excluded from health information exchanges, which frequently serve as an impetus for other providers to use EHRs. The other two factors are financial and regulatory.
This section will provide insights into the contents included in this U.S. behavioral health care software and services market report and help gain clarity on the structure of the report to assist readers in navigating smoothly.
Market drivers and restraints
Key market opportunities prioritized
Latest strategic developments
Market size, estimates, and forecast from 2017 to 2030
Market estimates and forecast for product segments up to 2030
Regional market size and forecast for product segments up to 2030
Market estimates and forecast for application segments up to 2030
Regional market size and forecast for application segments up to 2030
Company financial performance
GET A FREE SAMPLE
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.
Contact us now to get our best pricing.
ESOMAR certified & member